Basic Information
DefEYE is a rapidly growing ophthalmic company with a mission to transform and personalize the treatment of ophthalmic care. The company’s platform offers a range of decellularized human amniotic and placental basement membrane products, available in tri-layer and single-layer structures that preserve the natural extracellular matrix architecture, in various sizes and shapes, with room-temperature shelf stability, and compatibility with both office-based and surgical applications. This enables eye care physicians and medical institutions to utilize regenerative biotools for managing complex ocular surface diseases, pterygium repair, and other surgical interventions.
DefEYE, Inc.
Florida,United States of America
15~50 people
January 01, 2022
--

